Skip to main content

AtlasClear Holdings Inc

For the period ended Dec 31, 2023. Filed Apr 16, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Apr 16, 2024

ATCH$0.13-2.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signature Page

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

​AtlasClear Holdings, Inc.
​​​
Date: April 16, 2024​/s/ Robert McBey
​Name:Robert McBey
​Title:Chief Executive Officer
​​(Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

​​
Signature​Title​Date
​​​​​
/s/ Robert McBey​Chief Executive Officer and Chairman of the Board​April 16, 2024
Robert McBey​(Principal Executive Officer)​​
​​​​​
/s/ Richard Barber​Chief Financial Officer​April 16, 2024
Richard Barber​(Principal Financial and Accounting Officer)​​
​​​​​
/s/ John Schaible​Chief Strategy Officer and Director​April 16, 2024
John Schaible​​​​
​​​​​
/s/ Craig Ridenhour​Chief Business Development Officer and Director​April 16, 2024
Craig Ridenhour​​​​
​​​​​
/s/ Steven J. Carlson​Director​April 16, 2024
Steven J. Carlson​​​​
​​​​​
/s/ Thomas J. Hammond​Director​April 16, 2024
Thomas J. Hammond​​​​
​​​​​
/s/ Sandip I. Patel​Director​April 16, 2024
Sandip I. Patel​​​​
​​​​​
/s/ James Tabacchi​Director​April 16, 2024
James Tabacchi​​​​
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.